Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

Jun Yin(University of Electronic Science and Technology of China), Qing Zhou(Hanzhong Central Hospital)
Nature Medicine
July 24, 2023
10.1038/s41591-023-02469-3
Cited by 86

Related Papers

Deconvolution of single-cell multi-omics layers reveals regulatory heterogeneity
|Nature Communications|2019|252
The deficiency of adenosine deaminase type 2-results of therapeutic intervention
|Pediatric Rheumatology|2015|33
<i>PADI4</i> rs2240337 G&gt;A polymorphism is associated with susceptibility of esophageal squamous cell carcinoma in a Chinese population
|Oncotarget|2017|4